China Shineway Pharmaceutical Group Ltd 02877
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HKD 9.21
- Day Range
- HKD 9.16–9.29
- 52-Week Range
- HKD 6.55–10.72
- Bid/Ask
- HKD 9.18 / HKD 9.21
- Market Cap
- HKD 7.60 Bil
- Volume/Avg
- 51,000 / 777,193
Key Statistics
- Price/Earnings (Normalized)
- 6.53
- Price/Sales
- 1.39
- Dividend Yield (Trailing)
- 6.29%
- Dividend Yield (Forward)
- 6.29%
- Total Yield
- 6.29%
Company Profile
China Shineway Pharmaceutical Group Ltd is an investment holding company in the People's Republic of China. Principally, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, and others of which injection generates maximum revenue to the company.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 3,436
- Website
- http://www.shineway.com.hk
Comparables
Valuation
|
Metric
|
02877
|
00867
|
01672
|
|---|---|---|---|
Price/Earnings (Normalized) | 6.53 | 6.49 | — |
Price/Book Value | 0.91 | 1.03 | 0.53 |
Price/Sales | 1.39 | 2.00 | 22.47 |
Price/Cash Flow | 6.14 | 6.52 | — |
Price/Earnings
02877
00867
01672
Financial Strength
|
Metric
|
02877
|
00867
|
01672
|
|---|---|---|---|
Quick Ratio | 2.97 | 3.91 | 16.51 |
Current Ratio | 3.35 | 4.29 | 16.58 |
Interest Coverage | 419.36 | 59.97 | −1,693.40 |
Quick Ratio
02877
00867
01672
Profitability
|
Metric
|
02877
|
00867
|
01672
|
|---|---|---|---|
Return on Assets (Normalized) | 10.83% | 14.91% | −5.34% |
Return on Equity (Normalized) | 13.16% | 17.41% | −5.59% |
Return on Invested Capital (Normalized) | 12.66% | 15.18% | −9.56% |
Return on Assets
02877
00867
01672
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Clypygbpp | Lpds | $73.0 Bil | |
MKKGY
| Merck KGaA ADR | Kmqmjmgwvj | Hxnld | $70.8 Bil | |
HLN
| Haleon PLC ADR | Qycxlhd | Bjcj | $38.2 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Qllnsczsb | Bmcky | $14.6 Bil | |
VTRS
| Viatris Inc | Hkwynqbv | Pdfv | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Stzjbnvl | Jkmv | $12.6 Bil | |
CTLT
| Catalent Inc | Lfmsjhm | Rmjfry | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Pkjtsppd | Mptv | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Qdpxvbyx | Fmnvv | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Hmjdbgrz | Fftpdp | $3.6 Bil |